BCL2A1 and neoplasm: It is accepted that BFL1 prevents apoptosis under specific physiological settings, and that BFL1 contributes to tumour progression and drug resistance in selected types of human cancer [16–23], akin to BCL2, BCLXL and MCL1 [24].